Scientists Find Liver Protein That Cuts Bad Cholesterol

Scientists at UT Southwestern Medical Center just uncovered a hidden control system in your liver that determines how much harmful cholesterol enters your bloodstream.

The protein, called HELZ2, works like a dial that regulates cholesterol-carrying particles linked to clogged arteries and heart disease. What makes this discovery exciting is that it works completely differently from current treatments like statins.

Dr. Zhao Zhang and his team found that HELZ2 controls cholesterol at an earlier stage than anyone expected. Instead of dealing with cholesterol after it's already made, HELZ2 shortens the lifespan of genetic instructions before cholesterol-carrying proteins can even form.

"Most previous research focused on what happens to apoB after it's already made," said Dr. Yiao Jiang, who worked on the study. "What surprised us is that HELZ2 acts much earlier, by controlling how long the apoB 'message' survives before the protein is even produced."

The researchers discovered HELZ2's role while studying unusual fat patterns in mice livers. When HELZ2 activity increased, mice produced fewer harmful cholesterol particles in their blood and showed better protection against atherosclerosis, the artery-clogging disease that causes heart attacks and strokes.

The discovery does come with an interesting trade-off. Turning up HELZ2 activity lowered blood cholesterol but increased fat storage in the liver, while turning it down did the opposite.

"We can think of HELZ2 as a kind of dial between the liver and the bloodstream," Dr. Zhang explained. "That balance makes HELZ2 especially interesting as a potential therapeutic target."

Why This Inspires

This breakthrough represents more than just another cholesterol study. It reveals an entirely new pathway that scientists didn't know existed, opening possibilities for treatments that work at the genetic instruction level rather than after the damage starts.

The discovery could eventually help millions of people who struggle with high cholesterol or can't tolerate current medications. It also offers new hope for tackling fatty liver disease, which affects nearly one in four adults worldwide.

The research team used a sophisticated genetic screening system developed by Nobel Prize winner Dr. Bruce Beutler, showing how fundamental science continues to unlock nature's hidden solutions. Published in the American Heart Association journal Circulation, the findings give doctors and researchers a completely new molecular tool for fighting heart disease.

Scientists believe that carefully adjusting HELZ2 activity could one day reduce dangerous cholesterol levels while managing liver health at the same time. Future treatments might give doctors more precision than ever before in protecting patients from cardiovascular disease.